Alfa Chemistry Materials 5 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| mPEG5K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Molecular formula: average Mn 5000. |  |
| mPEG5K-Silane | Methoxy PEG silanes are used for surface modification and deactivation of glass or silica. Uses: Bioconjugation, drug delivery, peg hydrogels, crosslinkers, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Silane. Molecular formula: average Mn 5,000. | |
| mPEG5-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2-[2-[2-[2- (2-methoxyethoxy) ethoxy]ethoxy]ethoxy]ethanamine. Molecular formula: 251.32g/mol. Mole weight: C11H25NO5. COCCOCCOCCOCCOCCN. InChI= 1S / C11H25NO5 / c1-13-4-5-15-8-9-17-11-10-16-7-6-14-3 -2-12 / h2-12H2, 1H3. WGQYVGMCDPUCEJ-UHFFFAOYSA-N. | |
| mPEG5-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2-[2-[2-[2- (2-methoxyethoxy) ethoxy]ethoxy]ethoxy]ethanol. Molecular formula: 252.3g/mol. Mole weight: C11H24O6. COCCOCCOCCOCCOCCO. InChI= 1S / C11H24O6 / c1-13-4-5-15-8-9-17-11-10-16-7-6-14-3 -2-12 / h12H, 2-11H2, 1H3. SLNYBUIEAMRFSZ-UHFFFAOYSA-N. | |
| mPEG5-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2-[2-[2-[2- (2-methoxyethoxy) ethoxy]ethoxy]ethoxy]ethanethiol. Molecular formula: 268.37g/mol. Mole weight: C11H24O5S. COCCOCCOCCOCCOCCS. InChI= 1S / C11H24O5S / c1-12-2-3-13-4-5-14-6-7-15-8-9-16-10- 11-17 / h17H, 2-11H2, 1H3. PNMCHSOJDWEEKK-UHFFFAOYSA-N. | |
| mPEG6-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG6-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: imino- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethylimino] azanium. Molecular formula: average Mn 6000. Mole weight: C13H28N3O6+. COCCOCCOCCOCCOCCOCCN=[N+]=N. InChI= 1S / C13H28N3O6 / c1-17-4-5-19-8-9-21-12-13-22-11-10-20 -7-6-18-3-2-15-16-14 / h14H, 2-13H2, 1H3 / q + 1. KZFRTKCDHGYEIH-UHFFFAOYSA-N. | |
| mPEG6-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 295.37g/mol. Mole weight: C13H29NO6. COCCOCCOCCOCCOCCOCCN. InChI= 1S / C13H29NO6 / c1-15-4-5-17-8-9-19-12-13-20-11-10-18 -7-6-16-3-2-14 / h2-14H2, 1H3. JDTWBXXBTWYNAT-UHFFFAOYSA-N. | |
| mPEG6-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG6-Hydroxyl. Product ID: 2-[2-[2-[2-[2- (2-methoxyethoxy) ethoxy]ethoxy]ethoxy]ethoxy]ethanol. Molecular formula: 296.36g/mol. Mole weight: C13H28O7. [H]OCCOC. 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. XNWFRZJHXBZDAG-UHFFFAOYSA-N. | |
| mPEG6-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 3- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoic acid. Molecular formula: 368.42g/mol. Mole weight: C16H32O9. COCCOCCOCCOCCOCCOCCOCCC(=O)O. InChI= 1S / C16H32O9 / c1-19-4-5-21-8-9-23-12-13-25-15-14-24 -11-10-22-7-6-20-3-2-16 (17) 18 / h2-15H2, 1H3, (H, 17, 18). NOPQIPMESCUIHH-UHFFFAOYSA-N. | |
| mPEG6-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Molecular formula: 312.42g/mol. Mole weight: C13H28O6S. COCCOCCOCCOCCOCCOCCS. InChI= 1S / C13H28O6S / c1-14-2-3-15-4-5-16-6-7-17-8-9-18-10- 11-19-12-13-20 / h20H, 2-13H2, 1H3. FCNSUDTWFXNQBG-UHFFFAOYSA-N. | |
| mPEG7-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG7-Azide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 7000. | |
| mPEG7-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanamine. Molecular formula: 339.42g/mol. Mole weight: C15H33NO7. COCCOCCOCCOCCOCCOCCOCCN. InChI= 1S / C15H33NO7 / c1-17-4-5-19-8-9-21-12-13-23-15-14-22 -11-10-20-7-6-18-3-2-16 / h2-16H2, 1H3. IQQSLHPGFFGOJW-UHFFFAOYSA-N. | |
| mPEG7-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxy-PEG7-Hydroxyl. Product ID: 2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 340.41g/mol. Mole weight: C15H32O8. [H]OCCOC. 1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3. XNWFRZJHXBZDAG-UHFFFAOYSA-N. | |
| mPEG7-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 3- [2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoic acid. Molecular formula: 412.5g/mol. Mole weight: C18H36O10. COCCOCCOCCOCCOCCOCCOCCOCCC(=O)O. InChI= 1S / C18H36O10 / c1-21-4-5-23-8-9-25-12-13-27-16-17-28 -15-14-26-11-10-24-7-6-22-3-2-18 (19) 20 / h2-17H2, 1H3, (H, 19, 20). JHUSQXBQANBSDC-UHFFFAOYSA-N. | |
| mPEG7-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- (2-methoxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanethiol. Molecular formula: 356.5g/mol. Mole weight: C15H32O7S. COCCOCCOCCOCCOCCOCCOCCS. InChI= 1S / C15H32O7S / c1-16-2-3-17-4-5-18-6-7-19-8-9-20-10- 11-21-12-13-22-14-15-23 / h23H, 2-15H2, 1H3. PVSKDHZQTUFAEZ-UHFFFAOYSA-N. | |
| (M-Terphenyl-5'-Yl)Trimethylsilane | (M-Terphenyl-5'-Yl)Trimethylsilane. Group: Small molecule semiconductor building blockssemiconductor blocks. Alternative Names: 3,5-Diphenyl-1-trimethylsilylbenzene; Trimethyl(m-terphenyl-5'-yl)silane. CAS No. 128388-53-4. Product ID: (3,5-diphenylphenyl)-trimethylsilane. Molecular formula: 302.49 g/mol. Mole weight: C21H22Si. C[Si] (C) (C)C1=CC (=CC (=C1)C2=CC=CC=C2)C3=CC=CC=C3. InChI=1S/C21H22Si/c1-22 (2, 3)21-15-19 (17-10-6-4-7-11-17)14-20 (16-21)18-12-8-5-9-13-18/h4-16H, 1-3H3. GCYRLUSIWVFXEZ-UHFFFAOYSA-N. >98%. | |
| Multi-Walled Carbon Nanotubes Dispersion, Butylacetate Dispersion,2- 3 wt % | Multi-Walled Carbon Nanotubes Dispersion, Butylacetate Dispersion,2- 3 wt %. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Multi-Walled Carbon Nanotubes Dispersion, dimethylformamide,2- 3 wt % | Multi-Walled Carbon Nanotubes Dispersion, dimethylformamide,2- 3 wt %. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Multi-Walled Carbon Nanotubes Dispersion, isopropanol dispersion,2- 3wt % | Multi-Walled Carbon Nanotubes Dispersion, isopropanol dispersion,2- 3wt %. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| MWCNT-Ni Type 1 Carbon Nanotubes Multi Walled, Nickel coated | MWCNT-Ni Type 1 Carbon Nanotubes Multi Walled, Nickel coated. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT-Ni Type 2 Carbon Nanotubes Multi Walled , Nickel coated | MWCNT-Ni Type 2 Carbon Nanotubes Multi Walled , Nickel coated. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT-Ni Type 3 Carbon Nanotubes Multi Walled , Nickel coated | MWCNT-Ni Type 3 Carbon Nanotubes Multi Walled , Nickel coated. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT-Ni Type 4 Carbon Nanotubes Multi Walled , Nickel coated | MWCNT-Ni Type 4 Carbon Nanotubes Multi Walled , Nickel coated. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 10 Carbon Nanotubes Multi-Walled | MWCNT Type 10 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 11 Carbon Nanotubes Multi-Walled | MWCNT Type 11 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 12 Carbon Nanotubes Multi-Walled | MWCNT Type 12 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 13 Carbon Nanotubes Multi-Walled | MWCNT Type 13 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 14 Carbon Nanotubes Multi-Walled | MWCNT Type 14 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 15 Carbon Nanotubes Multi-Walled | MWCNT Type 15 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 16 Carbon Nanotubes Multi-Walled Short | MWCNT Type 16 Carbon Nanotubes Multi-Walled Short. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 17 Carbon Nanotubes Multi-Walled Short | MWCNT Type 17 Carbon Nanotubes Multi-Walled Short. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 18 Carbon Nanotubes Multi-Walled Short | MWCNT Type 18 Carbon Nanotubes Multi-Walled Short. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 19 - Carbon Nanotubes Multi Walled (Conducting) | MWCNT Type 19 - Carbon Nanotubes Multi Walled (Conducting). Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 1 Carbon Nanotubes Multi Walled | MWCNT Type 1 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 2 Carbon Nanotubes Multi Walled | MWCNT Type 2 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 3 Carbon Nanotubes Multi Walled | MWCNT Type 3 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 4 Carbon Nanotubes Multi Walled | MWCNT Type 4 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 5 Carbon Nanotubes Multi Walled | MWCNT Type 5 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 6 Carbon Nanotubes Multi Walled | MWCNT Type 6 Carbon Nanotubes Multi Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 7 Carbon Nanotube Multi Walled (Graphitized) | MWCNT Type 7 Carbon Nanotube Multi Walled (Graphitized). Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 8 Carbon Nanotubes Multi-Walled | MWCNT Type 8 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| MWCNT Type 9 Carbon Nanotubes Multi-Walled | MWCNT Type 9 Carbon Nanotubes Multi-Walled. Group: Nanotubes. CAS No. 308068-56-6. | |
| m-Xylylenediphosphonic Acid, ≥97% | m-Xylylenediphosphonic Acid, ≥97%. Group: Self assembly and contact printing. CAS No. 144052-40-4. Product ID: [3- (phosphonomethyl) phenyl]methylphosphonic acid. Molecular formula: 266.12g/mol. Mole weight: C8H12O6P2. C1=CC(=CC(=C1)CP(=O)(O)O)CP(=O)(O)O. InChI=1S/C8H12O6P2/c9-15(10, 11)5-7-2-1-3-8(4-7)6-16(12, 13)14/h1-4H, 5-6H2, (H2, 9, 10, 11)(H2, 12, 13, 14). PYWZCUXISXXGMI-UHFFFAOYSA-N. | |
| Myristic Acid | Also called tetradecanoic acid, myristic acid is a fractionated saturated fatty acid that occurs naturally in certain fats and oils including nutmeg butter, coconut oil, and palm oil. Nutmeg, palm oil and coconut oil contain high levels of myristic acid. It is widely used as raw material in the production of emulsifiers, anionic & nonionic surfactants, ester & flavors. Saponification value 243-249. Uses: All kinds of personal care products including soaps, cleansing creams, lotions, hair conditioners, shaving products. Group: Pressure & heat sensitive recording materials solubility enhancing reagents heat & pressure sensitive dyespolymers. Alternative Names: N-Tetradecoic acid. CAS No. 544-63-8. Product ID: Tetradecanoic acid. Molecular formula: 228.37. Mole weight: C14H28O2. CCCCCCCCCCCCCC(=O)O. InChI=1S / C14H28O2 / c1-2-3-4-5-6-7-8-9-10-11-12-13-14 (15) 16 / h2-13H2, 1H3, (H, 15, 16). TUNFSRHWOTWDNC-UHFFFAOYSA-N. 99%. | |
| Myristic Acid, Reagent | Tetradecanoic acid is an oily white crystalline solid. (NTP, 1992);DryPowder; Liquid; OtherSolid; OtherSolid, Liquid; PelletsLargeCrystals; Solid; Solid; colourless to pale yellow, odourless liquid;hard, white, or faintly yellowish, somewhat glossy, crystalline solid. Group: Pressure & heat sensitive recording materials. CAS No. 544-63-8. Product ID: tetradecanoic acid. Molecular formula: 228.37g/mol. Mole weight: C14H28O2. CCCCCCCCCCCCCC(=O)O. InChI=1S / C14H28O2 / c1-2-3-4-5-6-7-8-9-10-11-12-13-14 (15) 16 / h2-13H2, 1H3, (H, 15, 16). TUNFSRHWOTWDNC-UHFFFAOYSA-N. | |
| Mytilus edulis foot protein-1 | Mytilus edulis foot protein-1 is one of several proteins in the byssal adhesive plaque of the mussel M. edulis. The high content of 3,4-dihydroxyphenylalanine and its localization near the plaque-substrate interface have often prompted speculation that Mefp plays a key role in adhesion. Uses: A solution of mefp-1 for general applications such as formation of surface coatings, attaching particles or polymers to surfaces or adhesive compositions that are insensitive to water. a surface coating of mefp-1 alters the surface to be highly hydrophilic and allows for attachment of other biological or non-biological components such as proteins, particles or polymers. Group: Natural polymers and biopolymers. Alternative Names: MEFP-1. Pack Sizes: 500 μL in glass insert. | |
| N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine | N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine. Group: Small molecule semiconductor building blocks. CAS No. 1448185-87-2. Product ID: N-(4-phenylphenyl)dibenzothiophen-4-amine. Molecular formula: 351.5g/mol. Mole weight: C24H17NS. C1=CC=C (C=C1)C2=CC=C (C=C2)NC3=CC=CC4=C3SC5=CC=CC=C45. InChI=1S/C24H17NS/c1-2-7-17 (8-3-1) 18-13-15-19 (16-14-18) 25-22-11-6-10-21-20-9-4-5-12-23 (20) 26-24 (21) 22/h1-16, 25H. SHLTUEMNYNAKHE-UHFFFAOYSA-N. | |
| N-[2-(N-Vinylbenzylamino)ethyl]-3-aminopropyltrimethoxysilane Hydrochloride, (30-40 Percent in Methanol) | N-[2-(N-Vinylbenzylamino)ethyl]-3-aminopropyltrimethoxysilane Hydrochloride, (30-40 Percent in Methanol). Group: Silane coupling agents. CAS No. 34937-00-3. | |
| N-[2-(p-Bromocinnamylamino)ethyl]-5-Isoquinoline Sulfonamide, 98% | N-[2-(p-Bromocinnamylamino)ethyl]-5-Isoquinoline Sulfonamide, 98%. Group: other glass and ceramic materials. CAS No. 127243-85-0. Product ID: N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5-sulfonamide. Molecular formula: 446.4g/mol. Mole weight: C20H20BrN3O2S. C1=CC2=C (C=CN=C2)C (=C1)S (=O) (=O)NCCNCC=CC3=CC=C (C=C3)Br. InChI=1S/C20H20BrN3O2S/c21-18-8-6-16 (7-9-18)3-2-11-22-13-14-24-27 (25, 26)20-5-1-4-17-15-23-12-10-19 (17)20/h1-10, 12, 15, 22, 24H, 11, 13-14H2/b3-2+. ZKZXNDJNWUTGDK-NSCUHMNNSA-N. | |
| N3-PEG3500-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: N3-PEG-NH2. Molecular formula: average Mn 3,500. | |
| N3-PEG3500-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: N3-PEG-NHS, Azide-PEG-NHS, N3-PEG-NHS. Molecular formula: average Mn 3,500. | |
| N3-PEG5K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: N3-PEG-NH2. Molecular formula: average Mn 5000. | |
| N3-PEG5K-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: N3-PEG-NHS, Azide-PEG-NHS, N3-PEG-NHS. Molecular formula: average Mn 5000. | |
| N3 Red Dye, 95% | N3 Red Dye, 95%. Group: Dye-sensitized solar cell (dssc) materials. CAS No. 141460-19-7. Molecular formula: 705.6g/mol. Mole weight: C26H16N6O8RuS2. C1=CN=C (C=C1C (=O)O)C2=NC=CC (=C2)C (=O)O. C1=CN=C (C=C1C (=O)O)C2=NC=CC (=C2)C (=O)O. C (=[N-])=S. C (=[N-])=S. [Ru+2]. InChI=1S/2C12H8N2O4. 2CNS. Ru/c2*15-11 (16)7-1-3-13-9 (5-7)10-6-8 (12 (17)18)2-4-14-10; 2*2-1-3; /h2*1-6H, (H, 15, 16) (H, 17, 18); ; ; /q; ; 2*-1; +2. VMISXESAJBVFNH-UHFFFAOYSA-N. | |
| N-[3-(Trimethoxysilyl)propyl]-N'-(4-vinylbenzyl)ethylenediamine hydrochloride solution | N-[3-(Trimethoxysilyl)propyl]-N'-(4-vinylbenzyl)ethylenediamine hydrochloride solution. Uses: This product is suitable for scientific research. Group: Self-assembly materials. CAS No. 33401-49-9. Product ID: N'-[(4-ethenylphenyl)methyl]-N-(3-trimethoxysilylpropyl)ethane-1,2-diamine; hydrochloride. Molecular formula: 374.98. Mole weight: H2C=CHC6H4CH2NHCH2CH2NH (CH2)3Si (OCH3)3·HCl. Cl. CO[Si](CCCNCCNCc1ccc(C=C)cc1)(OC)OC. 1S/C17H30N2O3Si. ClH/c1-5-16-7-9-17 (10-8-16)15-19-13-12-18-11-6-14-23 (20-2, 21-3)22-4; /h5, 7-10, 18-19H, 1, 6, 11-15H2, 2-4H3; 1H. JWIKADZFCMEWBV-UHFFFAOYSA-N. | |
| N-[4-(1-Naphthyl)phenyl]-4-biphenylamine | N-[4-(1-Naphthyl)phenyl]-4-biphenylamine. Group: Small molecule semiconductor building blocks. Alternative Names: N-[4-(Naphthalen-1-yl)phenyl]-[1,1'-biphenyl]-4-amine. CAS No. 897921-59-4. Product ID: N-(4-naphthalen-1-ylphenyl)-4-phenylaniline. Molecular formula: 371.48. Mole weight: C28H21N. C1=CC=C (C=C1)C2=CC=C (C=C2)NC3=CC=C (C=C3)C4=CC=CC5=CC=CC=C54. InChI=1S/C28H21N/c1-2-7-21 (8-3-1)22-13-17-25 (18-14-22)29-26-19-15-24 (16-20-26)28-12-6-10-23-9-4-5-11-27 (23)28/h1-20, 29H. DOTSEUKJBPAPGG-UHFFFAOYSA-N. >98.0%(GC). | |
| N-(4-Biphenylyl)-1-naphthylamine | N-(4-Biphenylyl)-1-naphthylamine. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 446242-37-1. Product ID: N-(4-phenylphenyl)naphthalen-1-amine. Molecular formula: 295.4g/mol. Mole weight: C22H17N. C1=CC=C (C=C1)C2=CC=C (C=C2)NC3=CC=CC4=CC=CC=C43. InChI=1S/C22H17N/c1-2-7-17 (8-3-1) 18-13-15-20 (16-14-18) 23-22-12-6-10-19-9-4-5-11-21 (19) 22/h1-16, 23H. KDADHQHDRSAQDY-UHFFFAOYSA-N. | |
| N-(4-Biphenylyl)-2-biphenylamine | N-(4-Biphenylyl)-2-biphenylamine. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 1372775-52-4. Product ID: 2-phenyl-N-(4-phenylphenyl)aniline. Molecular formula: 321.4g/mol. Mole weight: C24H19N. C1=CC=C (C=C1)C2=CC=C (C=C2)NC3=CC=CC=C3C4=CC=CC=C4. InChI=1S/C24H19N/c1-3-9-19 (10-4-1)20-15-17-22 (18-16-20)25-24-14-8-7-13-23 (24)21-11-5-2-6-12-21/h1-18, 25H. LIBHEMBTFRBMOV-UHFFFAOYSA-N. | |
| N-(4-Biphenylyl)-2-naphthylamine | N-(4-Biphenylyl)-2-naphthylamine. Group: Small molecule semiconductor building blocks. CAS No. 6336-92-1. Product ID: N-(4-phenylphenyl)naphthalen-2-amine. Molecular formula: 295.4g/mol. Mole weight: C22H17N. C1=CC=C (C=C1)C2=CC=C (C=C2)NC3=CC4=CC=CC=C4C=C3. InChI=1S/C22H17N/c1-2-6-17 (7-3-1)19-10-13-21 (14-11-19)23-22-15-12-18-8-4-5-9-20 (18)16-22/h1-16, 23H. JUMBNTOZUIMCEL-UHFFFAOYSA-N. | |
| N-(4'-Bromo-4-biphenylyl)-N-phenyl-1-naphthylamine | N-(4'-Bromo-4-biphenylyl)-N-phenyl-1-naphthylamine. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 352359-42-3. Product ID: N-[4-(4-bromophenyl)phenyl]-N-phenylnaphthalen-1-amine. Molecular formula: 450.4g/mol. Mole weight: C28H20BrN. C1=CC=C (C=C1)N (C2=CC=C (C=C2)C3=CC=C (C=C3)Br)C4=CC=CC5=CC=CC=C54. InChI=1S/C28H20BrN/c29-24-17-13-21 (14-18-24) 22-15-19-26 (20-16-22) 30 (25-9-2-1-3-10-25) 28-12-6-8-23-7-4-5-11-27 (23) 28/h1-20H. JYAVHXABZQYLTH-UHFFFAOYSA-N. | |
| N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline | N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline. Group: Small molecule semiconductor building blocks. CAS No. 203710-89-8. Product ID: N-(4-bromophenyl)-3-methyl-N-(3-methylphenyl)aniline. Molecular formula: 352.3g/mol. Mole weight: C20H18BrN. CC1=CC (=CC=C1)N (C2=CC=C (C=C2)Br)C3=CC=CC (=C3)C. InChI=1S/C20H18BrN/c1-15-5-3-7-19 (13-15)22 (18-11-9-17 (21)10-12-18)20-8-4-6-16 (2)14-20/h3-14H, 1-2H3. WHBVFRPPFWBXEE-UHFFFAOYSA-N. | |
| N-(4-Bromophenyl)-N-phenyl-1-naphthylamine | N-(4-Bromophenyl)-N-phenyl-1-naphthylamine. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 138310-84-6. Product ID: N-(4-bromophenyl)-N-phenylnaphthalen-1-amine. Molecular formula: 374.3g/mol. Mole weight: C22H16BrN. C1=CC=C (C=C1)N (C2=CC=C (C=C2)Br)C3=CC=CC4=CC=CC=C43. InChI=1S/C22H16BrN/c23-18-13-15-20 (16-14-18) 24 (19-9-2-1-3-10-19) 22-12-6-8-17-7-4-5-11-21 (17) 22/h1-16H. ABMCIJZTMPDEGW-UHFFFAOYSA-N. | |
| N-(4-Butoxybenzylidene)-4-acetylaniline | N-(4-Butoxybenzylidene)-4-acetylaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: Ethanone, 1-[4-[[(4-butoxyphenyl)methylene]amino]phenyl]-. CAS No. 17224-18-9. Product ID: 1-[4-[ (4-butoxyphenyl) methylideneamino]phenyl]ethanone. Molecular formula: 295.38. Mole weight: C19H21NO2. CCCCOC1=CC=C (C=C1)C=NC2=CC=C (C=C2)C (=O)C. InChI=1S / C19H21NO2 / c1-3-4-13-22-19-11-5-16 (6-12-19) 14-20-18-9-7-17 (8-10-18) 15 (2) 21 / h5-12, 14H, 3-4, 13H2, 1-2H3. OCSNPDHAHJRADR-UHFFFAOYSA-N. 98%+. | |
| N-(4-Ethoxybenzylidene)-4-acetylaniline | N-(4-Ethoxybenzylidene)-4-acetylaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: 4'-Ethoxybenzylidene-4-aminoacetophenone. CAS No. 17224-17-8. Product ID: 1-[4-[ (4-ethoxyphenyl) methylideneamino]phenyl]ethanone. Molecular formula: 267.33. Mole weight: C17H17NO2. CCOC1=CC=C (C=C1)C=NC2=CC=C (C=C2)C (=O)C. InChI=1S / C17H17NO2 / c1-3-20-17-10-4-14 (5-11-17) 12-18-16-8-6-15 (7-9-16) 13 (2) 19 / h4-12H, 3H2, 1-2H3. HCDYNBNSFSMUIM-UHFFFAOYSA-N. 98%+. | |
| N-(4'-Iodobiphenyl-4-yl)-N-(m-tolyl)aniline | N-(4'-Iodobiphenyl-4-yl)-N-(m-tolyl)aniline. Group: Small molecule semiconductor building blockselectroluminescence materials. Alternative Names: N-(4'-Iodobiphenyl-4-yl)-N-phenyl-N-(m-tolyl)amine. CAS No. 195443-34-6. Product ID: N-[4-(4-iodophenyl)phenyl]-3-methyl-N-phenylaniline. Molecular formula: 461.35. Mole weight: C25H20IN. CC1=CC (=CC=C1)N (C2=CC=CC=C2)C3=CC=C (C=C3)C4=CC=C (C=C4)I. InChI=1S/C25H20IN/c1-19-6-5-9-25 (18-19)27 (23-7-3-2-4-8-23)24-16-12-21 (13-17-24)20-10-14-22 (26)15-11-20/h2-18H, 1H3. AKQZSFMSAULQQN-UHFFFAOYSA-N. >98.0%(HPLC). | |
| N-(4-Methoxy-2-hydroxybenzylidene)-4-butylaniline | N-(4-Methoxy-2-hydroxybenzylidene)-4-butylaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: N-(2-Hydroxy-p-anisal)-4-butylaniline. CAS No. 30633-94-4. Product ID: 2-[(4-butylphenyl)iminomethyl]-5-methoxyphenol. Molecular formula: 283.37. Mole weight: C18H21NO2. CCCCC1=CC=C (C=C1)N=CC2=C (C=C (C=C2)OC)O. InChI=1S / C18H21NO2 / c1-3-4-5-14-6-9-16 (10-7-14) 19-13-15-8-11-17 (21-2) 12-18 (15) 20 / h6-13, 20H, 3-5H2, 1-2H3. DFUYRNLWIOXVQP-UHFFFAOYSA-N. 98%+. | |
| N-(4-Methoxybenzylidene)-4-butylaniline | Cloudy light yellow liquid. (NTP, 1992). Uses: N-(4-methoxybenzylidene)-4-butylaniline (mbba) is majorly used in the development of liquid crystal cells. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: N-(p-Anisal)-4-butylaniline N-(p-Anisylidene)-4-butylaniline MBBA. CAS No. 26227-73-6. Product ID: N-(4-butylphenyl)-1-(4-methoxyphenyl)methanimine. Molecular formula: 267.37. Mole weight: C18H21NO. CCCCC1=CC=C(C=C1)N=CC2=CC=C(C=C2)OC. InChI=1S / C18H21NO / c1-3-4-5-15-6-10-17 (11-7-15) 19-14-16-8-12-18 (20-2) 13-9-16 / h6-14H, 3-5H2, 1-2H3. FEIWNULTQYHCDN-UHFFFAOYSA-N. >98.0%(GC)(T). | |
| N-[4-(tert-Butyl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine | N-[4-(tert-Butyl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine. Group: Small molecule semiconductor building blocks. CAS No. 944418-46-6. Product ID: N-(4-tert-butylphenyl)-9,9-dimethylfluoren-2-amine. Molecular formula: 341.5g/mol. Mole weight: C25H27N. CC1 (C2=CC=CC=C2C3=C1C=C (C=C3)NC4=CC=C (C=C4)C (C) (C)C)C. InChI=1S/C25H27N/c1-24 (2, 3) 17-10-12-18 (13-11-17) 26-19-14-15-21-20-8-6-7-9-22 (20) 25 (4, 5) 23 (21) 16-19/h6-16, 26H, 1-5H3. NVCQMRCDIJQSAP-UHFFFAOYSA-N. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.